The effector function of natural killer (NK) cells is modulated by surface expression of a range of killer-cell immunoglobulin-like receptors (KIRs) that interact with human leukocyte antigen (HLA) class I ligands. We describe the use of real-time polymerase chain reaction (PCR) assays that allow easy and quick detection of 16 KIR genes and the presence/absence of KIR-ligands based on allelic discrimination at codon 80 in the HLA-A/B Bw4 and HLA-C C1/C2 genes. These methods overcome the tedious and expensive nature of conventional KIR genotyping and HLA class I typing using sequence-specific primer (SSP) PCR, sequence-specific oligonucleotide (SSO) hybridization or sequence-based typing (SBT). Using these two cost-effective assays, we measured the frequencies of KIRs, KIR-ligands and KIR/KIR-ligand pairs in a cohort of Black women recruited in South Africa.
Introduction
outcomes as well as in pregnancy and transplantation complications (10, 16) . The presence of specific KIRs with or without their corresponding ligands can influence susceptibility to disease and/or improved response to therapy (10, (17) (18) (19) . Conventional KIR genotyping is done by sequence-specific primer polymerase chain reaction (SSP-PCR), and HLA class I typing is done by SSP-PCR, sequence-specific oligonucleotide (SSO) hybridization or sequence-based typing (SBT) assays. These methods are often cumbersome and expensive and require large quantities of high-quality genomic DNA. Amplified SSP products are visualized by agarose gel electrophoresis, which is time-consuming as well as hazardous if using ethidium bromide staining (16) .
We have optimized and validated two real-time PCR assays for KIR genotyping and identification of KIR-ligands using samples previously characterized by SSP-PCR and SBT. The KIR genotyping assay is able to determine the presence/absence of 16 KIR genes, while the KIR-ligand assay identifies the presence/absence of KIR-ligands (HLA-A/B Bw4, and HLA-C C1/C2). We then applied these new methods to identify KIR genotype, KIR-ligand frequencies and KIR/KIR-ligand pairs in a small South African cohort.
Methodology

Validation samples
Stored genomic DNA was available for 230 samples previously genotyped for KIR or HLA class I using commercial assays. The real-time PCR KIR genotyping assay was validated against 50 samples, consisting of 24 South African Black individuals and 26 Caucasians that were KIR genotyped by SSP-PCR. Importantly, all 16 KIR genes were represented in these samples. The real-time PCR KIR-ligand assay was validated against 220 samples that had been HLA typed by SBT, in which all variants at position 80 were represented. To accommodate HLA class I allelic variation, we tested samples from South African Black individuals (n = 107) and Caucasians (n = 83), as well as published HLA-A, -B and -C reference samples (n = 30) obtained from the International Histocompatibility Working Group (http://www.ihwg.org).
Study samples
Whole-blood ethylenediaminetetraacetic acid (EDTA) samples were collected from consenting Black women (n = 81) recruited from the Carletonville mining area, South Africa. A salting-out method (20) was used to extract genomic DNA from leukocytes isolated from 1 ml of whole blood. DNA concentration was measured on a nanodrop spectrophotometer (Thermo Scientific, Wilmington, MA). The study was approved by the Human Research Ethics Committee (Medical) at the University of the Witwatersrand and informed written consent was obtained from all participants.
KIR PCR primers and real-time PCR
To date, real-time PCR-based KIR genotyping and HLA KIR-ligand identification assays have been described by Alves et al. (21) and Koehler et al. (22) . In our system, we wished to avoid the use of fluorescent probe chemistry and nested PCR methods used by Koehler et al. (22) in favor of SYBR green chemistry. For our real-time KIR genotyping assay, we selected previously published KIR primer sequences (16, 21, 23) , which we mapped to updated KIR gene alignments in the Immuno Polymorphism Database (IPD) database (24) . A combination of primers was used to improve detection of KIR allelic variants, with the exception of KIR2DL3 and KIR3DP1, where a single primer set was used ( Table 1 ). The KIR2DL3 primer set detects all known alleles; however, the pseudogene KIR3DP1 primer set does not detect KIR3DP1*004 and KIR3DP1*009 alleles. Furthermore, an internal control gene galactosylceramidase (GALC ) (21) was included.
For real-time PCR amplification, each 5-μl reaction contained 2× SYBR Green master mix (Roche, Mannheim, Germany), 0.2 μM KIR-specific primers, 0.2 μM GALCspecific primers and 5 ng of genomic DNA. PCR cycling was performed in a 96-well format on an ABI PRISM 7500 real-time instrument (Applied Biosystems, Foster City, CA) as follows: 10 min at 95
• C, 30 cycles of 15 s at 95
• C and 1 min at 60
• C. Melt curve analysis was performed after cycling ( Figure 1A ) and could discriminate between GALC (T m = 74.89
• C) and the KIR amplicons (T m = 78.5.5
• C-85.9
• C), thereby making it simple to identify the presence/absence of specific KIR genes. The presence of an internal control amplicon ensured that the absence of a KIR amplicon was a true result.
KIR-ligand primers and real-time PCR
We designed our KIR-ligand primers from HLA class I alignments available at the International Immunogenetics Project (IMGT)/HLA database (25) to discriminate Bw4 from Bw6 allotypes at codon 80. Primers were synthesized with 3 locked nucleic acid (LNA) bases (Exiqon, Vedbaek, Denmark) in order to increase template specificity ( Table 2) . Each PCR included an internal positive control gene albumin (ALB) (26) . For real-time PCR amplification, each 5-μl reaction contained 2× SYBR Green master mix (Roche), 0.2 μM KIRspecific primers, 0.2 μM ALB-specific primers and 5 ng of genomic DNA. PCR cycling was performed in a 96-well format on an ABI PRISM 7500 real-time instrument (Applied Biosystems) as follows: 10 min at 95
• C, 30 cycles of 15 s at
95
• C, 5 s at 60
• C and 1 min at 72
• C. Melt curve analysis was performed after cycling ( Figure 1B) , and similar to the KIR assay, differences in melting temperature could discriminate between ALB (T m = 75.62
• C) and the KIR-ligand amplicons
High-resolution HLA typing
High-resolution (four-digit) HLA typing was performed on validation samples as follows: DNA was extracted from either peripheral blood mononuclear cells or granulocytes using the Pel-Freez DNA isolation kit (Dynal Biotech, Ullernchausseen, Norway). HLA-A, -B and -C typing was performed by DNA sequencing of exons 2, 3 and 4 using SBTexcellerator kits (Qiagen, Dusseldorf, Germany) on an ABI3100 Genetic Analyzer (Applied Biosystems) and assign-sbt v3.5 software (Conexio Genomics, Fremantle, Western Australia). Any ambiguities resulting from either polymorphisms outside the sequenced exons or identical heterozygote combinations were resolved using statistical methods (27) .
SSP-PCR KIR genotyping
KIR genotyping was performed on validation samples using either a commercially available kit, sequence-specific primer KIR PCR genotyping kit (Olerup, Loewengasse, Austria) or a published protocol (16) . These methods both detect the presence/absence of the following 16 KIR genes:
On the basis of individual KIR gene combinations, two genotype groups were stratified, the AA genotype with nine genes (KIR2DL1/3/4, KIR3DL1-3, KIR2DS4, KIR2DP1 and KIR3DP1 ) and the Bx genotype, which can be a mixture of AB or BB haplotypes. In addition, KIR Bx genotype numbers were assigned according to published nomenclature on the Allele Frequencies database (28) .
Data analysis
For both sets of data (SSP-PCR, SBT and real-time PCR), carrier frequencies for the observed KIR and KIR-ligands were determined by direct counting (individuals positive for the gene divided by the individuals tested per population × 100). Real-time PCR KIR and KIR-ligand assays were validated by direct comparison with SBT-and SSP-PCRbased typing results of the same samples.
Results
Validation of real-time PCR KIR assay
Using samples that represented the full spectrum of the KIR genes, we tested real-time PCR KIR assay on the KIR validation samples (n = 50) and compared our results to the gel-based (SSP-PCR) KIR genotyping kit (Olerup) and published methods (16) . We found the real-time PCR KIR assay was 100% concordant with conventional SSP-PCR methods ( Table 3) .
Validation of real-time PCR KIR-ligand assay
In comparison with the commercial high-resolution SBT method, the real-time KIR-ligand assay correctly genotyped 
KIR genotyping in a South African population group
KIR genotyping using the real-time PCR KIR assay showed similar gene frequencies to other South African population groups studied (29, 30) . We identified 20 different KIR genotype profiles (Table 5) , 2 of which have not been previously reported (Bx46 and Bx70 ) and 1 undescribed KIR 
KIR-ligand genotyping in a South African population group
Using the real-time PCR KIR-ligand assay, we determined the absence/presence of the HLA-A/B Bw4 and HLA-C C1/C2 motifs. At the HLA-A locus, 2.5% of individuals were homozygous for Bw4:I 80 (ligands for KIR3DL1/S1), 69.1% were homozygous for non-Bw4:T 80 
KIR/KIR-ligand pairs in a South African population group
KIR and KIR-ligand data, when taken together, allow receptor-ligand combinations to be determined (Table 6 ).
Within this relatively small South African cohort (n = 81), the frequency of activating KIR/KIR-ligand pairs was lower than that of the inhibitory KIR/KIR-ligand pairs. Activating KIR2DS1 paired with the HLA-C C2 ligand was found at a frequency of 16% and KIR3DS1 paired with the putative HLA-B Bw4 ligand was present in 6.2% of individuals. Inhibitory KIR genes (KIR2DL1/2/3 and KIR3DL1 ) and their ligands HLA-C C2, HLA-C C1, HLA-C C1 and HLA-A/B Bw4 were present at frequencies of 84%, 44%, 44% and 58%, respectively.
Discussion
We have developed a fast and effective tool to determine KIR and KIR-ligand profiles using real-time PCR and SYBR Green chemistry. Our KIR and KIR-ligand assays were validated against commercial and published methods and were found to be 100% and 99.1% concordant, respectively. The advantage of our assays compared to the commercial gel-based KIR SSP-PCR and HLA SBT methods, as well as published KIR/KIR-ligand typing methods, includes its low input DNA concentration, simple technique and ease of interpretation of results. To enhance detection of KIR genes that may contain sequence variation in the primer binding sites, multiple primers were used for all except three genes ( Table 1 ). In addition, each of the assays uses a single internal positive control gene with a melting peak significantly lower than the KIR and KIR-ligand amplicon melting peaks. This enables proper discrimination between the absence of a target gene and a failed PCR. Most importantly, the KIR and KIR-ligand assays are very cost-effective, costing as little as 15%-20% of the price of commercial KIR and SBT typing kits, provided the users have access to a real-time PCR instrument. However, with respect to the HLA SBT typing one must keep in mind the level of allele-specific detail that sequencing provides as opposed to the real-time KIR-ligand allotype designations (HLA-A/B Bw4 and HLA-C C1/C2 ). Our assay is a single-round detection using SYBR Green chemistry and melting curve analysis, which is cheaper and simpler than other real-time PCR methods that make use of fluorescent probes and multiple amplification steps (22) . Limitations of the KIR and KIR-ligand assay designs are that due to the large number of KIR and HLA genes described and allelic variation within these, certain alleles can be either undetected or misclassified. The KIR primers used detect all known allelic variants, except the pseudogene KIR3DP1 primer set which does not detect KIR3DP1*004 and KIR3DP1*00902. The KIR-ligand assay failed to detect HLA-B*38:02 as a Bw4:T 80 A 81 allotype, but was not likely due to a primer mismatch. Furthermore, the KIR-ligand primers were designed to discriminate Bw4 from Bw6 at codon 80. By definition, amino-acid residues at positions 77 and 80-83 are important in defining the Bw4 (NXXIALR, NXXTALR, SXXIALR, DXXTLLR and SXXTLLR) and Bw6 (SXXNLRG and GXXNLRG) amino-acid motifs (14, 31) . Therefore, a limitation of our approach is that unclassified HLA-B alleles such as HLA-B*44:11, B*51:50, B*57:08 and HLA-A*24:61 that contain amino-acid changes within the Bw4 motifs will be classified as Bw4. Likewise, unclassi- and B*73:01) and will be misclassified as Bw6 allotypes by our assay. Therefore, complimentary HLA typing would be necessary in the geographic areas where these alleles have high frequencies, such as HLA-B*46 in Asia. Likewise for KIR2DS4 ligand identification, which consists of HLA-A*11:01/02 and a subset of HLA-C alleles, further HLA typing would be necessary.
When applied to a small South African sample set, we found similar KIR gene frequencies to other published studies (29, 30) , and identified an unreported KIR genotype profile (with all KIR genes present with the exception of KIR2DL2, KIR2DL3, KIR2DS1, KIR2DS2 and KIR3DS1 ). In addition, paired KIR and KIR-ligand combinations could be determined showing a dominance of inhibitory compared to stimulatory KIR receptor pairings. Specific combinations of HLA and KIRs have been associated with higher risk for autoimmune disease (32, 33) and differential risk for certain infectious diseases (17, 19) , thus it remains to be seen how the representation of activating/inhibitory KIR genes and their ligand pairs might impact on disease susceptibility/resistance in our population.
Conventional KIR and HLA genotyping methodologies involve gel-based SSP-PCR and SBT methods, respectively. These methods can be expensive, labor intensive and timeconsuming. We describe an optimized and validated real-time PCR-based KIR and KIR-ligand assays that show high concordance with commercial KIR and HLA typing methods. Melt curve analysis offers straightforward determination of the presence/absence of KIRs or known HLA ligands for KIRs, thereby generating results much faster than conventional methods. In addition, the assay is inexpensive and allows for high-throughput data generation. Together, these two assays have relevance to understanding NK cell function in disease as well as in complications with pregnancy or bone marrow transplantation.
